Skip to Main Content

Author Details

Daniel Klevebring
Karolinska Institutet
2009
33
22
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
29506270Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia.J Natl Cancer Inst2018
29633761Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2018
29625580Expression levels of long non-coding RNAs are prognostic for AML outcome.J Hematol Oncol2018
27587435Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.Clin Cancer Res2017
28167833Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.Leukemia2017
26950096Gene regulatory mechanisms underpinning prostate cancer susceptibility.Nat Genet2016
27901097Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.Sci Rep2016
27165105Determining breast cancer histological grade from RNA-sequencing data.Breast Cancer Res2016
27402876An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Hum Mol Genet2016
27210762Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.Cell Rep2016
26830453Study design requirements for RNA sequencing-based breast cancer diagnostics.Sci Rep2016
25529635Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Am J Hum Genet2015
25922084Exome sequencing of contralateral breast cancer identifies metastatic disease.Breast Cancer Res Treat2015
25652398Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Hum Mol Genet2015
25133800Evaluation of exome sequencing to estimate tumor burden in plasma.PLoS One2014
25248036Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.Nat Commun2014
24998755Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo.Breast Cancer Res2014
22502944Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.Eur Urol2013
23776131CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.EMBO Mol Med2013
23569271Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.Proc Natl Acad Sci U S A2013
23540573Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.Am J Hum Genet2013
23265383The mitochondrial and autosomal mutation landscapes of prostate cancer.Eur Urol2013
23276153Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP).J Proteome Res2013
22042635Antibody-based protein profiling of the human chromosome 21.Mol Cell Proteomics2012
23139805Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy.PLoS One2012
22622811Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.Breast Cancer Res Treat2012
20386591Increased throughput by parallelization of library preparation for massive sequencing.PLoS One2010
21126332Analysis of transcript and protein overlap in a human osteosarcoma cell line.BMC Genomics2010
21179022Defining the transcriptome and proteome in three functionally different human cell lines.Mol Syst Biol2010
20360838In-depth transcriptome analysis reveals novel TARs and prevalent antisense transcription in human cell lines.PLoS One2010
19781670Validation of serum protein profiles by a dual antibody array approach.J Proteomics2009
20021695Genome-wide profiling of populus small RNAs.BMC Genomics2009
19841682Automation of cDNA synthesis and labelling improves reproducibility.J Biomed Biotechnol2009
  • 1 - 33 of 33

Recommended Authors

Travers Ching
Adaptive Biotechnologies
Career Start Year 2014
Number of shared co-authors 0
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 2
Asha A Nair
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 12
Christopher A Maher
Washington University in St Louis
Career Start Year 2006
Number of shared co-authors 1
Wendell D Jones
Department of Bioinformatics and Clinical Systems
Career Start Year 2006
Number of shared co-authors 0
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 2
Paul M Krzyzanowski
Ontario Institute for Cancer Research
Career Start Year 2005
Number of shared co-authors 1
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 1
Elisa Napolitano E Ferreira
A.C.Camargo Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 7
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 4
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 13
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 1
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 8
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 9
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
Marco A Marra
University of British Columbia
Career Start Year 1993
Number of shared co-authors 3
Jean-Pierre A Kocher
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 11
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 17

Collaborators

Johan Lindberg
Karolinska Institute
Co-authored papers 14
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 12
Per Hall
Co-authored papers 11
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 7
Joakim Lundeberg
KTH Royal Institute of Technology
Co-authored papers 6
David Van Den Berg
Co-authored papers 6
Wei Zheng
Co-authored papers 6
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 6
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 6
Alison M Dunning
Co-authored papers 6
Jirong Long
Co-authored papers 6
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 6
Anna H Wu
University of Southern California
Co-authored papers 6
Diether Lambrechts
Co-authored papers 6
Irene L Andrulis
University of Toronto
Co-authored papers 6
Fergus J Couch
Mayo Clinic
Co-authored papers 6
Yu-Tang Gao
Co-authored papers 6
Julia A Knight
Co-authored papers 6
Douglas F Easton
University of Cambridge
Co-authored papers 6
Caroline Seynaeve
Erasmus Medical Center
Co-authored papers 6
Graham G Giles
Co-authored papers 6
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 6
Xiao-Ou Shu
Co-authored papers 6
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 6
Brian E Henderson
University of Southern California
Co-authored papers 6
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 6
Børge G Nordestgaard
Co-authored papers 6
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 6
Christopher A Haiman
University of Southern California
Co-authored papers 6
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 6
Release 1.2